Tag Archives: BCO

Top 5 Medical Stocks To Buy For 2019

Wright Medical Group (NASDAQ: WMGI) is one of 26 public companies in the “Surgical appliances & supplies” industry, but how does it compare to its peers? We will compare Wright Medical Group to related businesses based on the strength of its dividends, risk, earnings, profitability, analyst recommendations, valuation and institutional ownership.

Profitability

Get Wright Medical Group alerts:

This table compares Wright Medical Group and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Wright Medical Group -27.19% -3.78% -1.01%
Wright Medical Group Competitors -295.40% -52.45% -18.29%

Earnings & Valuation

This table compares Wright Medical Group and its peers revenue, earnings per share and valuation.

Top 5 Medical Stocks To Buy For 2019: Telecom Italia S.P.A.(TI)

Advisors’ Opinion:

  • [By Shane Hupp]

    Hawaiian Telcom HoldCo (NYSE: TI) and Telecom Italia (NYSE:TI) are both utilities companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability and valuation.

  • [By Ethan Ryder]

    TIM (NYSE: TI) and ORBCOMM (NASDAQ:ORBC) are both utilities companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, earnings, institutional ownership, analyst recommendations and dividends.

  • [By Logan Wallace]

    Press coverage about Telecom Italia (NYSE:TI) has trended somewhat positive this week, Accern Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Telecom Italia earned a coverage optimism score of 0.12 on Accern’s scale. Accern also assigned media headlines about the utilities provider an impact score of 46.0240684230122 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Top 5 Medical Stocks To Buy For 2019: Archrock, Inc.(AROC)

Advisors’ Opinion:

  • [By Tyler Crowe]

    Oil and gas infrastructure specialist Archrock (NYSE:AROC) and its former subsidiary Archrock Partners were once a textbook case of an overaggressive business that got rocked by crashing oil and gas prices. The company bet heavily on the need for compression horsepower to force oil and gas from wells to pipelines, and took on considerable leverage to do so. When demand dried up from lower production volumes, Archrock was stuck with a fleet of inactive compression equipment and a massive debt load.

  • [By Logan Wallace]

    Engineers Gate Manager LP boosted its stake in Archrock Inc (NYSE:AROC) by 241.6% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 95,336 shares of the energy company’s stock after purchasing an additional 67,426 shares during the period. Engineers Gate Manager LP’s holdings in Archrock were worth $834,000 at the end of the most recent quarter.

  • [By Motley Fool Transcribing]

    Archrock (NYSE:AROC) Q4 2018 Earnings Conference CallFeb. 20, 2019 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top 5 Medical Stocks To Buy For 2019: Enstar Group Limited(ESGR)

Advisors’ Opinion:

  • [By Andy Pai]

    Akre capital often holds positions for over ten years. As long as a company is able to keep increasing its economic value, the firm will hold a stock. Although the firm is a long-term investor, Akre doesn't attribute its success to ‘buy and hold' investing, but to the quality of the companies they buy. Some of the companies' long-term holdings have included Markel Corporation (NYSE: MKL), Dollar Tree, Inc. (NASDAQ: DLTR) and Enstar Group Ltd. (NASDAQ: ESGR).

  • [By Logan Wallace]

    Enstar Group (NASDAQ: ESGR) and Kemper (NYSE:KMPR) are both mid-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, institutional ownership, dividends, valuation and earnings.

  • [By Stephan Byrd]

    BidaskClub cut shares of Enstar Group (NASDAQ:ESGR) from a hold rating to a sell rating in a report issued on Saturday morning.

    Several other analysts have also recently issued reports on ESGR. TheStreet cut Enstar Group from a b- rating to a c+ rating in a research note on Tuesday, May 29th. ValuEngine cut Enstar Group from a buy rating to a hold rating in a research note on Wednesday, May 2nd.

Top 5 Medical Stocks To Buy For 2019: Brink's Company (BCO)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Thursday was a largely down day for the stock market, with the Dow Jones Industrial Average taking the biggest hit of the major benchmarks. The global turmoil over trade got a lot closer to home as the U.S. imposed new restrictions that led the Canadian government to issue retaliatory tariffs in response. Yet many broader-based measures of the market fell only slightly, showing that much of what drives the economy isn’t as dependent on trade as traditional industrial giants. Good news also sent some key stocks higher. Madrigal Pharmaceuticals (NASDAQ:MDGL), Brink’s (NYSE:BCO), and Applied Optoelectronics (NASDAQ:AAOI) were among the best performers on the day. Here’s why they did so well.

  • [By Shane Hupp]

    BridgeCoin (CURRENCY:BCO) traded 6.3% lower against the dollar during the one day period ending at 7:00 AM ET on June 26th. During the last week, BridgeCoin has traded down 27.1% against the dollar. One BridgeCoin coin can currently be bought for approximately $0.86 or 0.00013872 BTC on major exchanges. BridgeCoin has a total market capitalization of $23.29 million and approximately $23,296.00 worth of BridgeCoin was traded on exchanges in the last day.

  • [By Joseph Griffin]

    BridgeCoin (CURRENCY:BCO) traded 7.5% lower against the US dollar during the one day period ending at 17:00 PM Eastern on June 15th. One BridgeCoin coin can currently be bought for $1.24 or 0.00019057 BTC on major exchanges. In the last week, BridgeCoin has traded down 33.1% against the US dollar. BridgeCoin has a market cap of $33.52 million and approximately $15,787.00 worth of BridgeCoin was traded on exchanges in the last day.

  • [By Max Byerly]

    BridgeCoin (CURRENCY:BCO) traded 8.5% lower against the dollar during the 1 day period ending at 15:00 PM ET on July 1st. BridgeCoin has a market cap of $29.27 million and approximately $9,187.00 worth of BridgeCoin was traded on exchanges in the last 24 hours. One BridgeCoin coin can currently be bought for $1.08 or 0.00017157 BTC on popular cryptocurrency exchanges. Over the last week, BridgeCoin has traded 34.1% higher against the dollar.

  • [By Max Byerly]

    Shares of Brink’s (NYSE:BCO) have earned a consensus rating of “Buy” from the nine research firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and six have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $99.50.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Brink’s (BCO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Medical Stocks To Buy For 2019: Innodata Inc.(INOD)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Innodata (NASDAQ:INOD) will be releasing its Q1 2018 earnings data before the market opens on Tuesday, May 8th.

    Innodata (NASDAQ:INOD) last announced its earnings results on Thursday, March 8th. The technology company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $15.66 million for the quarter. Innodata had a negative return on equity of 10.94% and a negative net margin of 8.30%.

  • [By Logan Wallace]

    Luzich Partners LLC lifted its stake in shares of Innodata Inc (NASDAQ:INOD) by 4.9% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,316,550 shares of the technology company’s stock after acquiring an additional 61,944 shares during the period. Innodata accounts for approximately 1.5% of Luzich Partners LLC’s portfolio, making the stock its 12th biggest position. Luzich Partners LLC owned about 5.09% of Innodata worth $1,514,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Media coverage about Innodata (NASDAQ:INOD) has trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Innodata earned a media sentiment score of 0.10 on Accern’s scale. Accern also gave news articles about the technology company an impact score of 47.3485759085159 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Top Low Price Stocks To Own For 2019

AT&T (NYSE:T) could offer customers a streaming television package for the low, low price of $0 per month in the near future.

During AT&T CEO Randall Stephenson’s testimony in the Department of Justice’s case against his company, blocking its potential acquisition of Time Warner (NYSE:TWX), he noted the company is planning a $15 per month sports-free streaming bundle called AT&T Watch.

Wells Fargo analyst Jennifer Fritzsche said the service will be available to everyone, but AT&T will offer it for free to its wireless customers. AT&T currently offers a $15 discount on any DirecTV Now bundle to its unlimited wireless data plan subscribers, so it would effectively be offering the same discount for customers who opt for the sport-free AT&T Watch. AT&T also offers free HBO to its unlimited subscribers.

AT&T has said it’s seen a lot of success by bundling video products with its wireless plans, and it’s seen a couple of copycat attempts by T-Mobile and Sprint. AT&T Watch is yet another move to differentiate its service.

Top Low Price Stocks To Own For 2019: Rigel Pharmaceuticals Inc.(RIGL)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Thursday ended in the red for most major benchmarks on Wall Street, with the Dow trading down by triple digits at times before climbing back toward the close. After having bounced back sharply in recent days, stocks seemed to lose upward momentum, and interest rate fears returned to the market. The yield on the 10-year Treasury bond once again moved above the 2.9% mark, and shorter-term Treasurys had yields reach levels they haven’t seen in years. Yet even though the overall market was ready to take a break, some companies still enjoyed good news that lifted their shares. Bank of New York Mellon (NYSE:BK), Snap-on (NYSE:SNA), and Rigel Pharmaceuticals (NASDAQ:RIGL) were among the best performers on the day. Here’s why they did so well.

  • [By Logan Wallace]

    Rock Springs Capital Management LP raised its holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) by 4.0% in the first quarter, Holdings Channel reports. The fund owned 2,575,000 shares of the biotechnology company’s stock after buying an additional 100,000 shares during the period. Rock Springs Capital Management LP’s holdings in Rigel Pharmaceuticals were worth $9,116,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Rigel Pharmaceuticals (RIGL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Low Price Stocks To Own For 2019: Brink's Company (BCO)

Advisors’ Opinion:

  • [By Joseph Griffin]

    BridgeCoin (CURRENCY:BCO) traded 7.5% lower against the US dollar during the one day period ending at 17:00 PM Eastern on June 15th. One BridgeCoin coin can currently be bought for $1.24 or 0.00019057 BTC on major exchanges. In the last week, BridgeCoin has traded down 33.1% against the US dollar. BridgeCoin has a market cap of $33.52 million and approximately $15,787.00 worth of BridgeCoin was traded on exchanges in the last day.

  • [By Stephan Byrd]

    Wall Street brokerages predict that Brink’s (NYSE:BCO) will post earnings per share (EPS) of $0.76 for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Brink’s’ earnings, with the lowest EPS estimate coming in at $0.74 and the highest estimate coming in at $0.77. Brink’s reported earnings per share of $0.64 in the same quarter last year, which suggests a positive year over year growth rate of 18.8%. The company is expected to issue its next quarterly earnings results on Wednesday, July 25th.

  • [By Max Byerly]

    BridgeCoin (CURRENCY:BCO) traded 8.5% lower against the dollar during the 1 day period ending at 15:00 PM ET on July 1st. BridgeCoin has a market cap of $29.27 million and approximately $9,187.00 worth of BridgeCoin was traded on exchanges in the last 24 hours. One BridgeCoin coin can currently be bought for $1.08 or 0.00017157 BTC on popular cryptocurrency exchanges. Over the last week, BridgeCoin has traded 34.1% higher against the dollar.

  • [By Lisa Levin] Gainers
    Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks.
    Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday.
    Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days.
    Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension.
    China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86.
    J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings.
    Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory.
    Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48.
    Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results.
    The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash.
    Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
  • [By Shane Hupp]

    BridgeCoin (CURRENCY:BCO) traded 6.3% lower against the dollar during the one day period ending at 7:00 AM ET on June 26th. During the last week, BridgeCoin has traded down 27.1% against the dollar. One BridgeCoin coin can currently be bought for approximately $0.86 or 0.00013872 BTC on major exchanges. BridgeCoin has a total market capitalization of $23.29 million and approximately $23,296.00 worth of BridgeCoin was traded on exchanges in the last day.

Top Low Price Stocks To Own For 2019: Midatech Pharma PLC(MTP)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media stories about Midatech Pharma (NASDAQ:MTP) have trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Midatech Pharma earned a news sentiment score of 0.05 on Accern’s scale. Accern also gave press coverage about the company an impact score of 45.0428548550507 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.

  • [By Logan Wallace]

    News articles about Midatech Pharma (NASDAQ:MTP) have trended somewhat positive recently, according to Accern Sentiment. Accern identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Midatech Pharma earned a coverage optimism score of 0.04 on Accern’s scale. Accern also gave press coverage about the company an impact score of 47.6134155747452 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Money Morning Staff Reports]

    But before we show you our pick, here are the top 10 penny stocks to watch this week…

    Penny Stocks Current Share Price (as of Jan. 5) Jan. 2-5 Gain (as of Jan. 5)
    My Size Inc. (Nasdaq: MYSZ) $1.66 152.28%
    Cytori Therapeutics Inc. (Nasdaq: CYTX) $0.47 89.52%
    DelMar Pharmaceuticals Inc. (Nasdaq: DMPI) $1.675 58.02%
    CAS Medical Systems Inc. (Nasdaq: CASM) $1.09 55.71%
    China HGS Real Estate Inc. (Nasdaq: HGSH) $1.83 47.58%
    Aethlon Medical Inc. (Nasdaq: AEMD) $1.56 43.12%
    Midatech Pharma Plc. (Nasdaq: MTP) $1.23 43.01%
    Comstock Holding Cos. Inc. (Nasdaq: CHCI) $1.87 36.5%
    Cenveo Inc. (Nasdaq: CVO) $1.20 31.82%
    EV Energy Partners LP (Nasdaq: EVEP) $0.6844 31.62%

    FREE PROFIT ALERTS: Get real-time recommendations on the best penny stock opportunities the moment we release them. Just sign up here, it’s completely free…

Hot Value Stocks To Own Right Now

Jacobson & Schmitt Advisors LLC purchased a new position in Vanguard Total Stock Market ETF (NYSEARCA:VTI) in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 804 shares of the company’s stock, valued at approximately $109,000.

Several other hedge funds also recently made changes to their positions in VTI. Pacific Center for Financial Services lifted its holdings in Vanguard Total Stock Market ETF by 2.3% during the fourth quarter. Pacific Center for Financial Services now owns 98,208 shares of the company’s stock valued at $13,479,000 after purchasing an additional 2,203 shares in the last quarter. Colonial Trust Advisors purchased a new position in Vanguard Total Stock Market ETF during the fourth quarter valued at approximately $222,000. Aveo Capital Partners LLC lifted its holdings in shares of Vanguard Total Stock Market ETF by 20.5% in the fourth quarter. Aveo Capital Partners LLC now owns 29,496 shares of the company’s stock worth $4,048,000 after buying an additional 5,011 shares in the last quarter. Koshinski Asset Management Inc. lifted its holdings in shares of Vanguard Total Stock Market ETF by 46.9% in the fourth quarter. Koshinski Asset Management Inc. now owns 12,912 shares of the company’s stock worth $1,772,000 after buying an additional 4,121 shares in the last quarter. Finally, Bank of Hawaii lifted its holdings in shares of Vanguard Total Stock Market ETF by 6.7% in the fourth quarter. Bank of Hawaii now owns 1,051,823 shares of the company’s stock worth $144,363,000 after buying an additional 66,189 shares in the last quarter.

Hot Value Stocks To Own Right Now: Genomic Health, Inc.(GHDX)

Advisors’ Opinion:

  • [By Logan Wallace]

    Genomic Health (NASDAQ:GHDX) – Equities researchers at Piper Jaffray issued their Q2 2018 earnings per share (EPS) estimates for shares of Genomic Health in a research report issued on Wednesday, May 2nd. Piper Jaffray analyst W. Quirk expects that the medical research company will post earnings of $0.06 per share for the quarter. Piper Jaffray has a “Hold” rating and a $33.00 price target on the stock. Piper Jaffray also issued estimates for Genomic Health’s Q3 2018 earnings at $0.11 EPS, Q4 2018 earnings at $0.14 EPS, FY2018 earnings at $0.44 EPS, Q1 2019 earnings at $0.16 EPS, Q2 2019 earnings at $0.18 EPS, Q3 2019 earnings at $0.12 EPS, Q4 2019 earnings at $0.15 EPS and FY2019 earnings at $0.62 EPS.

  • [By Brian Orelli]

    Cancer-test maker Genomic Health (NASDAQ:GHDX) started the year on a high note, posting double-digit revenue growth, and would have turned a profit if not for an $8.5 millionone-time charge for stopping development of the Oncotype SEQ Liquid Select test, which was announced on the last quarterly call.

Hot Value Stocks To Own Right Now: Callaway Golf Company(ELY)

Advisors’ Opinion:

  • [By Shane Hupp]

    Callaway Golf (NYSE:ELY) insider Alex Mitchell Boezeman sold 47,012 shares of Callaway Golf stock in a transaction dated Friday, May 4th. The shares were sold at an average price of $17.19, for a total value of $808,136.28. Following the completion of the sale, the insider now owns 107,512 shares of the company’s stock, valued at $1,848,131.28. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

  • [By Joseph Griffin]

    Granite Springs Asset Management LLC increased its position in shares of Callaway Golf (NYSE:ELY) by 7.4% during the 1st quarter, Holdings Channel reports. The fund owned 72,500 shares of the company’s stock after buying an additional 5,000 shares during the quarter. Granite Springs Asset Management LLC’s holdings in Callaway Golf were worth $1,186,000 at the end of the most recent quarter.

Hot Value Stocks To Own Right Now: Brink's Company (BCO)

Advisors’ Opinion:

  • [By Matthew Cochrane]

    Over the past few years, the Brink’s Company (NYSE:BCO) has defied expectations in a dinosaur industry: cash security and management. While a slew of fintech companies have risen with the almost singular purpose of ridding the world of paper currency, Brink’s has transformed itself into a multi-billion dollar cash management titan from its humble roots of transporting travelers’ valuables from train stations to hotel rooms more than a century and a half ago.

Hot Value Stocks To Own Right Now: Student Transportation Inc(STB)

Advisors’ Opinion:

  • [By Logan Wallace]

    Student Transportation Inc. (NASDAQ:STB) (TSE:STB) has been given an average rating of “Hold” by the eight brokerages that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell rating, four have given a hold rating and three have issued a buy rating on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $7.20.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Student Transportation (STB)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    One of the main goals of my premium newsletter High-Yield Investing is stability. I like industries that don’t go through unpredictable hot and cold cycles. Student Transportation (NYSE: STB) is a textbook example.

Hot Value Stocks To Own Right Now: Sealed Air Corporation(SEE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Celanese (NYSE: CE) and Sealed Air (NYSE:SEE) are both basic materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations.

Will This Company's Growth Strategy Drown It In Debt?

Over the past few years, the Brink’s Company (NYSE:BCO) has defied expectations in a dinosaur industry: cash security and management. While a slew of fintech companies have risen with the almost singular purpose of ridding the world of paper currency, Brink’s has transformed itself into a multi-billion dollar cash management titan from its humble roots of transporting travelers’ valuables from train stations to hotel rooms more than a century and a half ago.

Since CEO Douglas Pertz took the position in June 2016, Brink’s has crushed the market following a strategy of growth via acquisitions. In the company’s first quarter, non-GAAP revenue rose to $853 million, a 15% increase year over year, and adjusted EPS grew to $0.65, a 12% increase year over year. The company’s operating margin also improved to 8.4%, up from 7.2% in 2017’s first quarter.

Brink’s Metrics 2018 Q1 2017 Q1 Change
Revenue (non-GAAP) $853 million $740 million 15%
Adjusted EPS $0.65 $0.58 12%
Total debt $681 million $305 million 126%

Data source: Brink’s Company

While the company continues to show growth, investors have to wonder if the price it is paying in accruing debt is worth it. Let’s take a closer look at the company’s growth strategy, its accumulating mountain of debt, and whether the end result will be worth the price Brink’s pays to achieve it.

Chain and padlock wrapped around stack of hundred dollar bills

Brink’s Company has forged a cash management and protection business empire from humble beginnings but, thanks to accruing debt and the rising prominence of digital and electronic payments, its future is far from certain. Image source: Getty Images.

Brink’s 1.5 Strategy

Brink’s calls its strategy to grow via acquisitions its 1.5 Strategy. During the company’s first-quarter conference call, Pertz explained what the company had done through acquisitions during his tenure and what is was looking for in future acquisitions. He said:

With our organic initiatives continuing to gain traction, we’re just beginning to layer in additional growth through acquisitions. And as we said in the past, we call this our Strategy 1.5. We focus on acquisitions in our core business in core geographies, what we call core-core and also, on core acquisitions in adjacent geographies or core-adjacent … We continue to have a strong pipeline of acquisition targets that offer new opportunities to increase route density, add new customers and capture cost synergies with strong returns as we’ve seen so far.

In 2017, the company paid $365 million to complete six acquisitions that are expected to add between $60 and $70 million in EBITDA this year. Pertz said the plan is to spend an additional $800 million on new acquisitions over the next two years which would bring the grand total to about $1.2 billion spent over a three year period. Concerning future acquisitions, he insisted, “We will remain disciplined in our goal to achieve both synergy models between 6 and 7x EBITDA.”

A growing amount of debt

The problem is the company is accumulating an awful lot of debt while it pursues this growth-by-acquisition strategy. Last March, the company’s total debt was $301 million; this quarter, it rose to $681 million, a whopping 126% increase year over year! If it completes its targeted spending for future acquisitions in 2018 and 2019 and meets all of its cost synergy goals, Brink’s expects to hold $1.1 billion in debt by the end of 2019, a 61% increase from today’s levels. This would give the company a 1.5 leverage ratio, defined as net debt divided by adjusted EBITDA. That’s a lot of debt!

Are these acquisitions worth it? Well, it depends. If the company can meet its price of 6-7 times EBITDA, they very well could be. However, targeting the right acquisitions, whether core-core or core-adjacent, is absolutely critical. Brink’s management also needs to ensure its synergy goals are realistic when it takes on a new company and its culture so that its 6-7 times EBITDA goal can be feasibly obtained– something easier said than done. Still, I would probably be on board with the company’s strategy if it wasn’t for one nagging concern.

Brink’s biggest concern

The biggest threat facing Brink’s is the very nature of the industry it inhabits. While cash will, for the foreseeable future, probably serve a purpose in the global economy, I don’t think it can be argued that its use will soon be on the decline. Mastercard Inc (NYSE:MA) has long maintained that about 85% of the world’s transactions were facilitated using cash. Last year, the company updated that number to being just above 80% and, given current trends, I believe this number will continue to fall.

Mastercard recently acquired Oltio, a South African mobile payments start-up. In the press release announcing the acquisition, Mastercard South Africa President Mark Elliott said “Too many consumers and merchants in the MEA region [Middle East-Africa] are stuck in a cash economy that doesn’t work for them. By combining our joint expertise, technologies and reach, we can bridge the divide between the region’s cash economies and the digital future, bringing the benefits of digital payments to more people and businesses.”

Mastercard and Visa Inc (NYSE:V) are working fast to enable consumers in developing economies to use QR codes, those black-and-white matrix images, to enable digital transactions. These are popular in emerging countries because they don’t require expensive hardware or a robust landline network for merchants to be able to accept card payments — only smartphones are required.

Visa is already seeing success with the international adoption of digital payments in economies only recently dominated by the use of cash. In its first-quarter conference call, Visa CEO Al Kelly said the number of merchants in India that could accept card payments had doubled to three million since the end of 2016.

Final takeaway

The question investors should ask is whether gaining share in what could soon be a declining market is worth the risk Brink’s deteriorating balance sheet presents. Given the company’s adjusted trailing twelve month EPS of $3.07, it currently trades for a P/E ratio of about 24.4. That’s almost right in line with the S&P 500 index’s average multiple. That just does not seem to be a compelling enough value to consider an investment in Brink’s at this time, especially considering its rising debt levels and its questionable total addressable market going forward.

Will This Company's Growth Strategy Drown It In Debt?

Over the past few years, the Brink’s Company (NYSE:BCO) has defied expectations in a dinosaur industry: cash security and management. While a slew of fintech companies have risen with the almost singular purpose of ridding the world of paper currency, Brink’s has transformed itself into a multi-billion dollar cash management titan from its humble roots of transporting travelers’ valuables from train stations to hotel rooms more than a century and a half ago.

Since CEO Douglas Pertz took the position in June 2016, Brink’s has crushed the market following a strategy of growth via acquisitions. In the company’s first quarter, non-GAAP revenue rose to $853 million, a 15% increase year over year, and adjusted EPS grew to $0.65, a 12% increase year over year. The company’s operating margin also improved to 8.4%, up from 7.2% in 2017’s first quarter.

Brink’s Metrics 2018 Q1 2017 Q1 Change
Revenue (non-GAAP) $853 million $740 million 15%
Adjusted EPS $0.65 $0.58 12%
Total debt $681 million $305 million 126%

Data source: Brink’s Company

While the company continues to show growth, investors have to wonder if the price it is paying in accruing debt is worth it. Let’s take a closer look at the company’s growth strategy, its accumulating mountain of debt, and whether the end result will be worth the price Brink’s pays to achieve it.

Chain and padlock wrapped around stack of hundred dollar bills

Brink’s Company has forged a cash management and protection business empire from humble beginnings but, thanks to accruing debt and the rising prominence of digital and electronic payments, its future is far from certain. Image source: Getty Images.

Brink’s 1.5 Strategy

Brink’s calls its strategy to grow via acquisitions its 1.5 Strategy. During the company’s first-quarter conference call, Pertz explained what the company had done through acquisitions during his tenure and what is was looking for in future acquisitions. He said:

With our organic initiatives continuing to gain traction, we’re just beginning to layer in additional growth through acquisitions. And as we said in the past, we call this our Strategy 1.5. We focus on acquisitions in our core business in core geographies, what we call core-core and also, on core acquisitions in adjacent geographies or core-adjacent … We continue to have a strong pipeline of acquisition targets that offer new opportunities to increase route density, add new customers and capture cost synergies with strong returns as we’ve seen so far.

In 2017, the company paid $365 million to complete six acquisitions that are expected to add between $60 and $70 million in EBITDA this year. Pertz said the plan is to spend an additional $800 million on new acquisitions over the next two years which would bring the grand total to about $1.2 billion spent over a three year period. Concerning future acquisitions, he insisted, “We will remain disciplined in our goal to achieve both synergy models between 6 and 7x EBITDA.”

A growing amount of debt

The problem is the company is accumulating an awful lot of debt while it pursues this growth-by-acquisition strategy. Last March, the company’s total debt was $301 million; this quarter, it rose to $681 million, a whopping 126% increase year over year! If it completes its targeted spending for future acquisitions in 2018 and 2019 and meets all of its cost synergy goals, Brink’s expects to hold $1.1 billion in debt by the end of 2019, a 61% increase from today’s levels. This would give the company a 1.5 leverage ratio, defined as net debt divided by adjusted EBITDA. That’s a lot of debt!

Are these acquisitions worth it? Well, it depends. If the company can meet its price of 6-7 times EBITDA, they very well could be. However, targeting the right acquisitions, whether core-core or core-adjacent, is absolutely critical. Brink’s management also needs to ensure its synergy goals are realistic when it takes on a new company and its culture so that its 6-7 times EBITDA goal can be feasibly obtained– something easier said than done. Still, I would probably be on board with the company’s strategy if it wasn’t for one nagging concern.

Brink’s biggest concern

The biggest threat facing Brink’s is the very nature of the industry it inhabits. While cash will, for the foreseeable future, probably serve a purpose in the global economy, I don’t think it can be argued that its use will soon be on the decline. Mastercard Inc (NYSE:MA) has long maintained that about 85% of the world’s transactions were facilitated using cash. Last year, the company updated that number to being just above 80% and, given current trends, I believe this number will continue to fall.

Mastercard recently acquired Oltio, a South African mobile payments start-up. In the press release announcing the acquisition, Mastercard South Africa President Mark Elliott said “Too many consumers and merchants in the MEA region [Middle East-Africa] are stuck in a cash economy that doesn’t work for them. By combining our joint expertise, technologies and reach, we can bridge the divide between the region’s cash economies and the digital future, bringing the benefits of digital payments to more people and businesses.”

Mastercard and Visa Inc (NYSE:V) are working fast to enable consumers in developing economies to use QR codes, those black-and-white matrix images, to enable digital transactions. These are popular in emerging countries because they don’t require expensive hardware or a robust landline network for merchants to be able to accept card payments — only smartphones are required.

Visa is already seeing success with the international adoption of digital payments in economies only recently dominated by the use of cash. In its first-quarter conference call, Visa CEO Al Kelly said the number of merchants in India that could accept card payments had doubled to three million since the end of 2016.

Final takeaway

The question investors should ask is whether gaining share in what could soon be a declining market is worth the risk Brink’s deteriorating balance sheet presents. Given the company’s adjusted trailing twelve month EPS of $3.07, it currently trades for a P/E ratio of about 24.4. That’s almost right in line with the S&P 500 index’s average multiple. That just does not seem to be a compelling enough value to consider an investment in Brink’s at this time, especially considering its rising debt levels and its questionable total addressable market going forward.

Top 10 High Tech Stocks To Buy For 2018

Sometimes it feels like our world is falling apart; global warming, global storming, extreme poverty, the glass ceiling, and racism highlight a list that could go on and on.  It also seems that many of our political leaders are failing to recognize their role as global stewards.  But all is not lost.  It is time for you at home and at work to step up and change things.

What does that mean?  Let’s start with who you are.  I’m assuming you want to live a meaningful and purposeful life while respecting all people and the environment. (If that isn’t the case, stop reading this article!) I’m also assuming you would want to do this at work as well as at home. Did you know that you could work for companies that share your core values?

Enter Conscious Capitalism

Top 10 High Tech Stocks To Buy For 2018: Brink's Company (The)(BCO)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    World Wrestling Entertainment (NYSE: WW) received a pair of downgrades after its earnings report came in below estimates.

    Sell-Side's Most Noteworthy Calls
    Baird downgraded Cardinal Health (NYSE: CAH) to Neutral.
    Imperial downgraded Brinks (NYSE: BCO) to In-Line.
    Jefferies upgraded AK Steel (NYSE: AKS) to Buy.
    Craig-Hallum upgraded LendingClub (NYSE: LC) to Buy.
    Deal Talk

    General Electric (NYSE: GE) was said to be in talks to acquire Baker Hughes (NYSE: BHI), according to sources as reported by Dow Jones. A deal could be valued at as much as $30 billion. However, Bloomberg later reported that a GE spokesperson said they're in talks with Baker Hughes regarding possible partnerships, but not an acquisition. Halliburton (NYSE: HAL) had attempted to acquire Baker Hughes in 2014, but the DoJ sued to block the deal valued at $35 billion.

  • [By Lee Jackson]

    Another hedge fund that is also a director at Brink’s Co. (NYSE: BCO) was busy selling stock this past week. Starboard parted with a total of 650,000 shares of the security and protection company at prices that fell between $51.47 and $52.05. The total for the sale was set at $34 million. Shares closed on Friday at $52.00. The consensus price target is $56, and the52-week range is $26.86 to $53.90.

Top 10 High Tech Stocks To Buy For 2018: Polo Ralph Lauren Corporation(RL)

Advisors’ Opinion:

  • [By Casey Wilson]

    Amazon has been a growing pain in the neck for low-price retailers like Wal-Mart Stores Inc. (NYSE:WMT) for some time, but even high-end specialty stores like Ralph Lauren Corp. (NYSE: RL) have struggled now that Amazon has crept into their sector.

  • [By Ben Levisohn]

    Hanesbrands was just one of many retail companies that got shellacked this week. Under Armour (UAA) tumbled 29% after missing earnings forecasts and cutting its guidance, while Deckers Outdoor (DECK) plunged 21% after its earnings missed the Street consensus, and Ralph Lauren (RL) plummeted 13% after its CEO stepped down.

  • [By Casey Wilson]

    Ralph Lauren Corp. (NYSE: RL) just became the latest company to fall victim to the “Retail Ice Age.”

    The 50-year-old American icon announced it shuttered its flagship store at Fifth Avenue and 55th Street in New York City on Tuesday (April 4). It will also close 50 other retail locations by the end of the fiscal year.

  • [By WWW.THESTREET.COM]

    The sidewalks outside stores like Armani, Dolce & Gabanna, Ralph Lauren (RL) , Gap (GPS) , Prada, Abercrombie & Fitch (AF) , Microsoft (MSFT) and Harry Winston are now lined with metal barricades. The strip commands some of the highest retail rents in the world, with the average annual rent being $3500 per square foot.

Top 10 High Tech Stocks To Buy For 2018: Live Ventures Incorporated(LIVE)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested going long onsmall cap real-time deal engine stock Live Ventures Inc (NASDAQ:LIVE):

Top 10 High Tech Stocks To Buy For 2018: ChannelAdvisor Corporation(ECOM )

Advisors’ Opinion:

  • [By Lisa Levin]

    ChannelAdvisor Corp (NASDAQ: ECOM) shares dropped 24 percent to $10.85 following Q4 results. ChannelAdvisor reported Q4 net income of $5.8 million on revenue of $31.8 million.

Top 10 High Tech Stocks To Buy For 2018: Level 3 Communications, Inc.(LVLT)

Advisors’ Opinion:

  • [By Ben Levisohn]

    A rumored merger with CenturyLink (CTL) sent Level 3 Communications (LVLT) soaring to the top of the S&P 500 today.

    Pixabay

    Shares of Level 3 Communications climbed 11% to $51.87 today, even as the S&P 500 declined 0.3% to 2,133.04. CenturyLink didn’t perform too badly, either: It gained 9.7% to $31.

  • [By Ben Levisohn]

    After opening up 0.6% this morning, Level Three Communications (LVLT) jumped as much as 5.9% on reports that it was considering ways to increase shareholder value (nudge nudge, wink wink, know what I mean?). Citigroup’s Michael Rollins and Neth Wiedemann offer their take:

    Online news source Benzinga recently tweeted that an industry source has told them Level 3 is “reviewing strategic alternatives to maximize holder value, including outright sale or large buyback”. Level 3 shares are up ~4% today after a ~3% move yesterday and shares are up ~10% over the past week. The company has not responded to the news, nor can we substantiate the speculation.

    Level 3 remains our top-pick within our coverage group given its growth, financial flexibility, valuation, and strategic optionality.Level 3 currently trades around ~10x our 2016 OIBDA estimate and ~11x our 2016 discretionary FCF estimate, which we believe is too cheap given its growth profile and deep strategic asset-mix of metro and long-haul fiber.

    We believe that Level 3′s extensive enterprise presence could be attractive for a cable player looking to move up-market and accelerate its investment from thesmall- to medium-sized businesses segment into the enterprise market. We also believe that Zayo Group Holdings (ZAYO) may be an attractive acquisition target for a cable company looking to accelerate an enterprise strategy. We also would not dismiss the possibility that Level 3 and Zayo could consider a merger scenario to become a larger competitor for the enterprise market against the incumbents AT&T (T) and Verizon Communications (VZ).

    Shares of Level 3 have gained 3.7% to $56.39 at 1:20 p.m. today, while Zayo Group Holdings has risen 1% to $28.78, AT&T has advanced 0.5% to $42.61, and Verizon Communications is up 0.7% to $55.87.

  • [By Benzinga News Desk]

    On Thursday afternoon, Wall Street Journal reported that CenturyLink (NYSE: CTL) was in advanced talks to merge with Level 3 Communications (NYSE: LVLT). Back on July 13, Benzinga Pro reported Level 3 was reviewing strategic alternatives.

Top 10 High Tech Stocks To Buy For 2018: Galaxy Resources Limited (GALXF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    ILC reminds me of Critical Elements [TSXV:CRE] (OTCQX:CRECF) having five projects (CRE has 11), and also of Galaxy Resources (ASX:GXY) (OTCPK:GALXF) by being diversified across brine and spodumene and across three continents. Also some similarity with Neo Lithium’s (OTC:NTTHF) [TSXV:NLC] early stage Argentinean brine project which I recently wrote about here. However, ILC trades at a much smaller market cap of US$8m to that of Critical Elements (US$85m) or Galaxy Resources (US$724m). This is partly due to ILC giving away significant percentages of their projects, and because they are still in the early stages of development.

Top 10 High Tech Stocks To Buy For 2018: MKS Instruments, Inc.(MKSI)

Advisors’ Opinion:

  • [By Monica Gerson]

    MKS Instruments, Inc. (NASDAQ: MKSI) is estimated to post its quarterly earnings at $0.33 per share on revenue of $177.19 million.

    Pioneer Natural Resources (NYSE: PXD) is projected to post a quarterly loss at $0.75 per share on revenue of $711.66 million.

Top 10 High Tech Stocks To Buy For 2018: Euro/Yen(EJ)

Advisors’ Opinion:

  • [By Belinda Cao]

    E-House China Holdings Ltd. (EJ), a real estate brokerage, gained 9.2 percent to $9.70, extending it advance to a third week. Its American depositary receipts retreated 3.1 percent Sept. 20 from the highest level since May 2011.

Top 10 High Tech Stocks To Buy For 2018: Terra Nitrogen Company L.P.(TNH)

Advisors’ Opinion:

  • [By Robert Rapier] While the MLP space is dominated by the oil and gas sector, in last week’s article we began to explore some of the more exotic master limited partnership offerings. This week we continue our exploration of nontraditional MLPs by looking at the partnerships supplying fertilizer.

    Rentech (Nasdaq: RTK) has been around for more than a decade, and it has shifted strategies several times. Full disclosure: Rentech’s Chief Technology Officer Harold Wright is a former manager of mine when we were both at ConocoPhillips, and I have visited Rentech’s facility in Commerce City, Colorado.

    For most of Rentech’s existence, the company has sought to commercialize alternative fuels. At one time it had ambitions to build a large coal-to-liquids (CTL) plant, but federal legislation ultimately nudged it instead into the biomass-to-liquids (BTL) space. The company did build a BTL demonstration plant, but ultimately shut it down and has now refocused its efforts on becoming “one of the largest wood processing companies in the world.”

    During its interesting journey as a company, Rentech acquired two ammonia nitrogen fertilizer facilities, which turned out to be a profit center that funded the alternative energy research. In November 2011, Rentech spun off this fertilizer business into an MLP called Rentech Nitrogen Partners LP (NYSE: RNF).

    In the months leading to the spin-off, RTK’s market capitalization was about $200 million. Rentech maintained 60 percent ownership of RNF, and three months after the spin-off RTK’s market cap had risen to $400 million, while investors had bid RNF up to $1 billion. Interestingly, RTK’s share of RNF was worth more than RTK’s entire market cap, a situation that persists. The market currently values Rentech at $482 million, while the valuation of Rentech Nitrogen Partners makes RTK’s 60 percent stake in RNF worth slightly more than $600 million — another illu

Top 10 High Tech Stocks To Buy For 2018: Covanta Holding Corporation(CVA)

Advisors’ Opinion:

  • [By Ian Wyatt, Publisher & Chief Investment Strategist, Wyatt Investment Research]

    Both of these stocks are overlooked, undervalued, and cash flow machines. The companies are Ascent Capital Group (ASCMA) and Covanta Holdings (CVA).

  • [By Lee Jackson]

    This company has seen solid insider buying over the past year. Covanta Holding Corp. (NYSE: CVA) is a world leader in providing sustainable waste and energy solutions. Annually, Covanta’s modern energy-from-waste facilities safely convert approximately 20 million tons of waste from municipalities and businesses into clean, renewable electricity to power 1 million homes and recycle approximately 500,000 tons of metal.

Top Medical Stocks To Buy Right Now

Several days ago Fitbit (FIT) and Dexcom (DXCM) announced they are partnering to develop CGM (continuous glucose monitoring) solutions for people living with diabetes. The first product will incorporate DXCM’s CGM data and bridge it with FIT’s new Ionic watch. Users of Android and iOS devices would be able to see “activity and glucose levels, right on their wrist.”

So what’s the big deal?

Th truth is that it isn’t such a big deal for DXCM. The company already sells and markets a similar product for both Android and iOS devices.

However, please note that the Ionic will have four days of battery life, which could be considered mission critical in such medical applications. Apple’s (AAPL) new iWatch 3 on the other hand clams to have up to 18 hours of battery life.

Also, the Ionic smartwatch has a built-in GPS tracker, an optical heart rate sensor, an accelerometer and a blood oxygen sensor. So perhaps DXCM and FIT might have more plans for medical Apps in the future. The AAPL iWatch does not have all those amenities, and to get the GPS tracker you have to fork out about $30 more.

Top Medical Stocks To Buy Right Now: Arc Wireless Solutions Inc.(ARCW)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggested small cap manufacturing and 3D printing service provider ARC Group WorldWide (NASDAQ: ARCW) as a short trade:

Top Medical Stocks To Buy Right Now: Signet Jewelers Limited(SIG)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Tuesday, utilities shares rose by just 0.3 percent. Meanwhile, top losers in the sector included Signet Jewelers Ltd. (NYSE: SIG), down 28 percent, and DSW Inc. (NYSE: DSW) down 12 percent.

  • [By Ben Levisohn]

    Signet Jewelers (SIG) soared to the top of the S&P 500 today after reporting better-than-expected earnings and offering a staunch defense of the company’s culture.

    Getty Images

    Signet Jewelersgained 8.7% to $70.02 today, while the S&P 500 ticked up 0.1% to 2,364.87.

    CFRA’s Efraim Levy still sees “risks” despite Signet’s defense of itself today:

    We lower our 12-month target by $4 to $81, or 11X our FY 18 (Jan.) EPS of $7.35 (reduced $0.30). We apply a P/E below SIG’s 10-year forward average of 13.4X, to reflect challenges of negative same-store sales, offset by our favorable longer-term view of SIG’s market position. SIG today addressed recent headlines, but we still see risks, despite implied upside potential to our target. Posts adjusted Jan-Q EPS of $4.03 vs. $3.63, in line with Capital IQ consensus and January guidance. Same-store sales fell an in-line 4.5%, dragged down by the Sterling Jewelers division.

    Signet Jewelers’ market capitalization rose to $4.9 billion today from $4.5 billion yesterday.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was Signet Jewelers Limited (NYSE: SIG) which rose about 5% to $52.34. The stocks 52-week range is $46.09 to $99.19. Volume was4 million compared to its average volume of 2 million.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Wednesday was Signet Jewelers Limited (NYSE: SIG) which traded down about 7% at $52.74. The stocks 52-week range is $46.09 to $86.35. Volume was 8.5 million, well above the daily average of 2.4 million shares.

  • [By Spencer Israel]

     

    Riot Blockchain Inc (NASDAQ: RIOT) – The Jan. 2015 high of $15.72 is the only resistance it has.
    General Electric Company (NYSE: GE) -The low of the move is a double bottom at $17.46 and  $17.50. That’s support.
    Overstock.com Inc (NASDAQ: OSTK) – The February 2005 high was $58.24, which is the only relevant resistance up here. On weakness, keep an eye on the all-time closing high of $56.65 made on Monday.
    Advance Auto Parts, Inc. (NYSE: AAP) – Is trying to fill the gap from earnings between $82.82 and $94.75.
    Tesla Motors Inc (NASDAQ: TSLA) – It needs to clear Friday’s close of $315.05 and Monday’s high of $315.50 to find support.
    Urban Outfitters, Inc. (NASDAQ: URBN) – There was a double close at $27.90 from Friday and $28.27 from Monday, so that’s resistance.
    DSW Inc. (NYSE: DSW) -The premarket low was $18.40. There are also four daily lows at the $18.40 area from early November, and the low of the move is $17.89.
    Signet Jewelers Ltd. (NYSE: SIG) – the premarket low was $61.50, which was the low of the move. There’s daily lows at the $61 area from mid-August, and another pair of lows at $60. Below that, there’s a gap area down to $52.95.
    Lowe’s Companies, Inc. (NYSE: LOW)- The Friday low was $79.17, and a pair of lows from Wednesday and Thursday at $78.27 and $78.23.
    Campbell Soup Company (NYSE: CPB) – The buy zone is between $45-$46. The low of the move was $44.99, flanked by the $45.14 low the following day.
    Dollar Tree, Inc. (NASDAQ: DLTR) – $99.93 and a big psychological number at $100.
    Burlington Stores Inc (NYSE: BURL) – The Monday low was $104.55. The all-time high and all-time closing high are $106.55 and $106.89, respectively. 
    Exxon Mobil Corporation (NYSE: XOM) – Big triple bottom at $80.

    Watch the full show below!

  • [By Peter Graham]

    A long term performance chart shows shares of Tiffany & Co and small cap Blue Nile Inc (NASDAQ: NILE) nowback in positive territory and trending up while Signet Jewelers Ltd (NYSE: SIG) has outperformedbut that outperformancestarted falling off late last year:

Top Medical Stocks To Buy Right Now: Sphere 3D Corp.(ANY)

Advisors’ Opinion:

  • [By Paul Ausick]

    Sphere 3D Corp. (NASDAQ: ANY) dropped about 36% Monday to post a new 52-week low of $0.23 after closing Friday at $0.36. The 52-week high is $2.00. Volume of around 4.3 million was more than 10 times the daily average of around 390,000 shares traded. The company said today that it has received an unsolicited proposal from an unnamed company to purchase certain of Sphere 3D’s assets.

Top Medical Stocks To Buy Right Now: Brink's Company (The)(BCO)

Advisors’ Opinion:

  • [By Lee Jackson]

    Another hedge fund that is also a director at Brink’s Co. (NYSE: BCO) was busy selling stock this past week. Starboard parted with a total of 650,000 shares of the security and protection company at prices that fell between $51.47 and $52.05. The total for the sale was set at $34 million. Shares closed on Friday at $52.00. The consensus price target is $56, and the52-week range is $26.86 to $53.90.

  • [By Benzinga News Desk]

    World Wrestling Entertainment (NYSE: WW) received a pair of downgrades after its earnings report came in below estimates.

    Sell-Side's Most Noteworthy Calls
    Baird downgraded Cardinal Health (NYSE: CAH) to Neutral.
    Imperial downgraded Brinks (NYSE: BCO) to In-Line.
    Jefferies upgraded AK Steel (NYSE: AKS) to Buy.
    Craig-Hallum upgraded LendingClub (NYSE: LC) to Buy.
    Deal Talk

    General Electric (NYSE: GE) was said to be in talks to acquire Baker Hughes (NYSE: BHI), according to sources as reported by Dow Jones. A deal could be valued at as much as $30 billion. However, Bloomberg later reported that a GE spokesperson said they're in talks with Baker Hughes regarding possible partnerships, but not an acquisition. Halliburton (NYSE: HAL) had attempted to acquire Baker Hughes in 2014, but the DoJ sued to block the deal valued at $35 billion.

Top Medical Stocks To Buy Right Now: Alphabet Inc.(GOOGL)

Advisors’ Opinion:

  • [By Douglas A. McIntyre]

    And those big tech stocks continue to sell off. Apple Inc. (NASDAQ: AAPL), Amazon, Alphabet Inc. (NASDAQ: GOOGL), Facebook and Microsoft Corp. (NASDAQ: MSFT) have lost over $100 billion in combined market cap in less than two weeks.

  • [By Sreekanth Anasa]

    Menlo Park, California-based Facebook Inc (NASDAQ:FB)reported stellar last quarter earnings and is still one of the best growth stories out on there in the market. To continue its growth story, the social networking giant recently made its biggest move to make itself a one-stop destination for video content by announcing a standalone TV App for videos and other videofeatures on Facebook. Mark Zuckerberg is a big fan of videos and described ‘video’ as a “mega-trend”. In one of our previous posts, we had already covered how Facebook is posing a threat to Alphabet Inc’s(NASDAQ:GOOGL) YouTube. However, in a recent coverage on FB stock fellow Amigobulls contributor had discussed the headwinds faced by Facebook Inc and one of these headwinds coupled with the risks associated with the social media giant’s video push could hurt FB stock. Let’s take a closer look.

  • [By Danny Vena]

    IBM isn’t the only player in this emerging field. While many big tech companies use varying degrees of artificial intelligence to help provide security for their cloud-computing operations, some are taking it to another level. In a research paper, Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL) division Google revealed that two neural networks had learned to build their own form of encryption, while a third was unable to crack that code. This is significant because they weren’t taught about encryption or given any examples of encrypted and decrypted messages. Two neural networks were instructed to send communications to each other, and keep that information secret from the third. This is likely an early development toward a dynamic system that learns to protect itself. In its conclusion, the paper states: “Finally, neural networks may be useful not only for cryptographic protections but also for attacks.”

  • [By Craig Jones]

    Pete Najarian spoke on CNBC's "Fast Money Halftime Report" about unusually high options activity in Alphabet Inc (NASDAQ: GOOGL) (NASDAQ: GOOG) and Microsoft Corporation (NASDAQ: MSFT).

  • [By Shanthi Rexaline]

    Alphabet Inc (NASDAQ: GOOGL) (NASDAQ: GOOG)’s consumer facing search engine was shut down in China in 2009, while China blocked Facebook Inc (NASDAQ: FB) in 2010. China claims that these companies show scant respect to Chinese laws. If at all these companies have to gain a foothold in the lucrative Chinese market, they may have to agree to the censorship rules laid down by the government and also help to bring to book, individuals who are perceived as threats to the nation.

  • [By WWW.THESTREET.COM]

    Founded in 2006, Spotify is now the world’s largest music-streaming service. In the U.S., Spotify once dominated the category of music streaming, which accounted for 51% of total music consumption in the U.S. according to Billboard. It faces intensifying competition from the music streaming divisions of Apple (AAPL) , Amazon (AMZN) and Alphabet (GOOGL) , though.

Top Medical Stocks To Buy Right Now: Just Hold Your Nose and Dive Into Under Armour Inc (UAA)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Under Armour’s (UAA) guidance last month was so bad that the stock lost a quarter of its value in just one day. Some analysts have stuck with the company, but many more have downgraded it. But that’s in the past. Now, Under Armour’s products are hitting the shelves at Kohl’s (KSS), and some have worried that it could dilute Under Armour’s brand. Kohl’s, meanwhile, has had troubles of its own–its stock is down 23% during the past three months–as investors have worried about the internet destroying retail as we know it. Which begs the question: Are you in trouble when you’re looking at Kohl’s as a savior?

    Baird’s Jonathan Komp and Benjamin Bray, however, see an opportunity for Under Armour to replace revenue lost when The Sports Authority liquidated. They explain why:

    Getty Images

    Under Armour has begun to arrive in stores and online at Kohl’s (covered by Mark Altschwager at Baird). We sense investors have been more positive on the opportunity for Kohl’s (adding another attractive national brand to its large/rapidly growing active category; characterized as “one of biggest brand launches in history”) than for Under Armour (given fears of brand dilution). Our initial review of the in-store execution is favorable and supportive of our belief that Under Armour can successfully sell a differentiated line of apparel and footwear that is highly incremental (could replace the ~$160 million of lost TSA revenue and grow much larger), yet distinct from offerings sold in more traditional athletic specialty and sporting goods distribution.

    Shares of Under Armour have gained 1.1% to $21.87 at 2:06 p.m. today, while Kohl’s has advanced 0.3% to Kohl’s.

  • [By Ben Levisohn]

    Nike’s drop today was vindication of sorts for my bearish call on Nike from December. At the time, I argued that Nike’s problems, including competition from Under Armour (UAA) and Adidas (AADDY) would continue into 2017, and that it probably wouldn’t outperform this year. That looked like a loser during the first months of the year, as Nike surged 14% this year through yesterday’s close. After today, however, it’s leading the Dow by just 1.5 points. Still a loser, but at least heading in the right direction.

  • [By JJ Kinahan]

    Competition has been growing in the athletic footwear and apparel market between Nike, Under Armour Inc (NYSE: UA) (NYSE: UAA) and Adidas. In recent months, Adidas has doubled its market share in the U.S. sport footwear market, according to market intelligence firm NDP, and both Nike and Adidas have continued to focus on Asia as an area for growth.

  • [By Bryan Murphy]

    Under Armour Inc (NYSE:UAA) has a problem.

    In light of the 70% pullback UAA shares have suffered since the September-2015 peak, that’s not exactly news to current and would-be shareholders. Under Armour may not be in the trouble most investors might suspect it means, though. The athletic apparel outfit has deeper, philosophical problems than a failing stock. This company has developed a bad habit, and may struggle to break out of it…. IF it can break out of it.

    Giving credit where it’s due, Under Armour has never had a problem growing the top line. Leveraging sponsorships/endorsements of some (very) high profile athletes like Tom Brady, Stephen Curry, and Jordan Spieth — just to name a few — the organization has mustered double-digit sales growth for several years now. The graphic below tells the tale; click on it to view the full-screen version.

  • [By Teresa Rivas]

    As the worlds of tech and athletics merge, Under Armour (UAA) is determined to lead the charge.

    Getty Images

    Cowens John Kernan reiterated a Market Perform rating on the stock Monday, given its valuation, but writes that the firms commitment to technology and innovation continues. He writes that the North American athletic category is very competitive, and he thinks Under Armour was more promotional through the holiday season than Nike (NKE). Nonetheless, the companys ongoing tech focus was evident at the Consumer Electronics Show last week.

    From his note:

    We attended CES 2017 in Las Vegas last week and met with UA’s Director of Investor Relations Carrie Gillard and Chief Digital Officer Mike Lee. We saw UA’s three new UA Record equipped running shoes, the Speedform Gemini 3 ($159.99), Speedform Velociti RE ($139.99) and Speedform Europa RE ($159.99). The shoes all include automatic tracking technology with UA’s MapMyRun program and also feature technology that allows for a short jumping test to measure muscle fatigue and recommend an appropriate intensity level for the athlete’s run or workout. All three shoes are available for pre-order now and will be sold on February 1st. UA also released Athlete Recovery Sleepwear ($80-$100), inspired by and developed with Tom Brady, which are designed with materials to help the body recover faster post-workout. The sleepwear is available for sale on UA’s website now. We note that CEO Kevin Plank was a keynote speaker at the conference.

    He writes that the companys latest update will also include a sleep analysis program, and that other fitness-related booths at CES, including Fitbit (FIT) did not feature new hardware.

    Under Armour is up 0.2% to $30.52 in recent trading.